Document is current
Any future updates will be listed below
-
Authors
Hatletvedt, Nora D.
Engebrethsen, Christina
Geisler, Jürgen
Geisler, Stephanie
Aas, Turid
Lønning, Per E.
Gansmo, Liv B.
Knappskog, Stian
-
Funding
Funding for this research was provided by:
University of Bergen
- License Information
-
More Information
Article History
Received: 22 November 2024
Accepted: 6 February 2025
First Online: 20 February 2025
Declarations
:
: The DDP-trial was approved by the Regional Committee for Medical and Health Research Ethics of Western Norway (REK-vest 06/3077) and all patients provided signed informed consent to participate in this study before inclusion. The trial was conducted in accordance with the Helsinki Declaration.
: Not applicable.
: PEL reports speaker’s honoraria from Illumina. SK reports speaker’s honoraria from Novartis and Pfizer. CE reports speaker´s honoraria from Novartis. All other authors had no disclosures.
